These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28570235)

  • 1. Five-Year Freedom From Target-Lesion Revascularization Using Excimer Laser Ablation Therapy in the Treatment of In-Stent Restenosis of Femoropopliteal Arteries.
    Shammas NW; Shammas GA; Arikat L; Shammas AN; Darrow A; Banerjee A; Rudy B
    J Invasive Cardiol; 2017 Jun; 29(6):207-208. PubMed ID: 28570235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).
    Dippel EJ; Makam P; Kovach R; George JC; Patlola R; Metzger DC; Mena-Hurtado C; Beasley R; Soukas P; Colon-Hernandez PJ; Stark MA; Walker C;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):92-101. PubMed ID: 25499305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and One-Year revascularization outcome of excimer laser ablation therapy in treating in-stent restenosis of femoropopliteal arteries: A retrospective review from a single center.
    Shammas NW; Shammas GA; Hafez A; Kelly R; Reynolds E; Shammas AN
    Cardiovasc Revasc Med; 2012; 13(6):341-4. PubMed ID: 23043953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center.
    Shammas NW; Shammas GA; Helou TJ; Voelliger CM; Mrad L; Jerin M
    Cardiovasc Revasc Med; 2012; 13(4):224-7. PubMed ID: 22575073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis.
    Armstrong EJ; Thiruvoipati T; Tanganyika K; Singh GD; Laird JR
    J Endovasc Ther; 2015 Aug; 22(4):506-13. PubMed ID: 26130385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in patient selection and outcomes between SilverHawk atherectomy and laser ablation in the treatment of femoropopliteal in-stent restenosis: a retrospective analysis from a single center.
    Shammas NW; Shammas GA; Jerin M
    J Endovasc Ther; 2013 Dec; 20(6):844-52. PubMed ID: 24325703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
    Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and Comparative Analysis of the Initial Results of Standard Balloon Angioplasty Versus Drug-Coated Balloons Alone Versus in Association With Laser-Excimer Atherectomy in the Treatment of Femoropopliteal Artery In-Stent Restenosis (INTACT).
    Ducasse E; Sapoval M; Brunet J; Commeau P; Goueffic Y; Sabatier J; Steinmetz E; Lermusiaux P; Rosset E; Caradu C
    J Endovasc Ther; 2024 Apr; ():15266028241248333. PubMed ID: 38659343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: twelve-month results from the PATENT study.
    Schmidt A; Zeller T; Sievert H; Krankenberg H; Torsello G; Stark MA; Scheinert D
    J Endovasc Ther; 2014 Feb; 21(1):52-60. PubMed ID: 24502484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JetStream Rotational and Aspiration Atherectomy in Treating In-Stent Restenosis of the Femoropopliteal Arteries: Results of the JETSTREAM-ISR Feasibility Study.
    Shammas NW; Shammas GA; Banerjee S; Popma JJ; Mohammad A; Jerin M
    J Endovasc Ther; 2016 Apr; 23(2):339-46. PubMed ID: 26921281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of femoropopliteal arteriosclerosis obliterans.
    Su Z; Li Y; Yang S; Guo J; Guo L; Gu Y
    Ann R Coll Surg Engl; 2022 Nov; 104(9):667-672. PubMed ID: 35446161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
    Kokkinidis DG; Hossain P; Jawaid O; Alvandi B; Foley TR; Singh GD; Waldo SW; Laird JR; Armstrong EJ
    J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jetstream Atherectomy in Treating Femoropopliteal In-Stent Restenosis: Meta-Analysis of the JETSTREAM-ISR and JET-ISR Trials.
    Shammas NW; Jones-Miller S; Shammas GA; Shammas WJ
    J Invasive Cardiol; 2020 Aug; 32(8):289-294. PubMed ID: 32737264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary: Excimer Laser in Treating Femoropopliteal In-Stent Restenosis: Can Early Success Be Maintained Over Long-term Follow-up?
    Shammas NW
    J Endovasc Ther; 2015 Aug; 22(4):514-7. PubMed ID: 26187975
    [No Abstract]   [Full Text] [Related]  

  • 15. Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of chronic obstructive femoropopliteal arterial disease.
    Liu H; Gu Y; Yang S; He J; Zhang F
    Exp Ther Med; 2020 Mar; 19(3):1887-1895. PubMed ID: 32104245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excimer laser atherectomy after unsuccessful angioplasty of TASC C and D lesions in femoropopliteal arteries.
    Wissgott C; Kamusella P; Lüdtke C; Andresen R
    J Cardiovasc Surg (Torino); 2013 Jun; 54(3):359-65. PubMed ID: 23138610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Femoropopliteal In-stent Restenosis Repair: Midterm Outcomes After Paclitaxel Eluting Balloon Use (PLAISIR Trial).
    Bague N; Julia P; Sauguet A; Pernès JM; Chatelard P; Garbé JF; Penillon S; Cardon JM; Commeau P; Planché O; Guyomarch B; Gouëffic Y
    Eur J Vasc Endovasc Surg; 2017 Jan; 53(1):106-113. PubMed ID: 27890526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Angioscopic Evaluation for Femoropopliteal In-Stent Restenosis Before and After Excimer Laser Atherectomy.
    Idemoto A; Okamoto N; Tanaka A; Mori N; Nakamura D; Yano M; Makino N; Egami Y; Shutta R; Tanouchi J; Nishino M
    Vasc Endovascular Surg; 2017 Jul; 51(5):335-337. PubMed ID: 28486842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis of the efficacy of debulking devices for in-stent restenosis of the femoropopliteal artery.
    Li X; Zhou M; Ding Y; Wang Y; Cai L; Shi Z
    J Vasc Surg; 2020 Jul; 72(1):356-366.e5. PubMed ID: 32093910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.